Directory
Sharyn Baker

Sharyn Baker, PharmD, PhD

Gertrude Parker Heer Chair in Cancer Research

Professor

Pharmaceutics and Pharmacology
Research Areas: Cancer, Clinical & Pre-Clinical Pharmacology, The Division of Pharmaceutics & Pharmacology
baker.2480@osu.edu
 Professional Website

Professional Interests

Dr. Baker’s cancer-relevant research interests broadly cover translational and clinical pharmacology of anti-cancer agents. Recently, her laboratory has focused on the preclinical development of anti-cancer agents for the treatment of acute myeloid leukemia (AML), with an emphasis on tyrosine kinase inhibitor (TKI) drug combinations. Dr. Baker’s research interests include developmental therapeutics for AML, clinical pharmacology of tyrosine kinase inhibitors, variability in anti-cancer drug disposition and investigational anti-cancer drug development.

Biography

Dr. Baker received her PharmD degree from the University of California at San Francisco, and her PhD degree in Medicine from the Erasmus University. She was an Assistant Professor of Oncology at Johns Hopkins University and then an Associate Member in the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital before moving to The Ohio State University (OSU) in 2015. Dr. Baker currently holds the Gertrude Parker Heer Chair in Cancer Research, and is Professor and Chair of the Division of Pharmaceutics and Pharmacology in the College of Pharmacy, and Associate Director of Shared Resources in the Comprehensive Cancer Center at OSU. She has authored over 190 peer-reviewed articles. She has served on multiple NIH Study Section and Review Panels and recently rotated off as a chartered member of the Developmental Therapeutics Study Section at the NCI. She has held editorial board appointments with various journals such as the Journal of Clinical Oncology. Dr. Baker has mentored over 40 postdoctoral PhD, PharmD and MD researchers and professional, graduate and undergraduate students, with many of them now working at academic institutions and in industry.

Education

  • 2004, Ph.D., Erasmus University Rotterdam, Medicine
  • 1991, Pharm.D., University of California, San Francisco, Pharmacy
  • 1986, B.A., Pacific Lutheran University, Biology
  • California State Board of Pharmacy No. 40219 (inac, California State Board of Pharmacy

Honors

  • 2017, ASCPT Clinical and Translational Science Award
  • 2022, The Ohio State University Distinguished Scholar Award

Publications